These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 32942070

  • 1. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
    Abdullaha M, Nuthakki VK, Bharate SB.
    Eur J Med Chem; 2020 Dec 01; 207():112761. PubMed ID: 32942070
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S, Ghobadian R, Mahdavi M, Nadri H, Moradi A, Akbarzadeh T, Najafi Z, Sharifzadeh M, Edraki N, Moghadam FH, Amini M.
    Daru; 2020 Dec 01; 28(2):463-477. PubMed ID: 32372339
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
    Jannat S, Balupuri A, Ali MY, Hong SS, Choi CW, Choi YH, Ku JM, Kim WJ, Leem JY, Kim JE, Shrestha AC, Ham HN, Lee KH, Kim DM, Kang NS, Park GH.
    Exp Mol Med; 2019 Feb 12; 51(2):1-18. PubMed ID: 30755593
    [Abstract] [Full Text] [Related]

  • 4. Blood-brain barrier permeable benzylpiperidin-4-yl-linked benzylamino benzamides as dual cholinesterase inhibitors.
    Banoo R, Nuthakki VK, Abdullaha M, Sharma M, Bharate SB.
    Drug Dev Res; 2022 Dec 12; 83(8):1791-1802. PubMed ID: 36112736
    [Abstract] [Full Text] [Related]

  • 5. Acetamide Derivatives of Chromen-2-ones as Potent Cholinesterase Inhibitors.
    Prasad S, Kumar B, Kumar S, Chand K, Kamble SS, Gautam HK, Sharma SK.
    Arch Pharm (Weinheim); 2017 Aug 12; 350(8):. PubMed ID: 28699213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
    Saxena A, Fedorko JM, Vinayaka CR, Medhekar R, Radić Z, Taylor P, Lockridge O, Doctor BP.
    Eur J Biochem; 2003 Nov 12; 270(22):4447-58. PubMed ID: 14622273
    [Abstract] [Full Text] [Related]

  • 9. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
    Nuthakki VK, Yadav Bheemanaboina RR, Bharate SB.
    Bioorg Chem; 2021 Feb 12; 107():104568. PubMed ID: 33418314
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S, Loganathan C, Sakayanathan P, Karthikeyan S, Stephen AD, Marimuthu DK, Ravichandran S, Sivalingam V, Thayumanavan P.
    Int J Biol Macromol; 2021 Aug 31; 185():750-760. PubMed ID: 34216669
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines.
    Basiri A, Abd Razik BM, Ezzat MO, Kia Y, Kumar RS, Almansour AI, Arumugam N, Murugaiyah V.
    Bioorg Chem; 2017 Dec 31; 75():210-216. PubMed ID: 28987876
    [Abstract] [Full Text] [Related]

  • 13. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
    Asadipour A, Alipour M, Jafari M, Khoobi M, Emami S, Nadri H, Sakhteman A, Moradi A, Sheibani V, Homayouni Moghadam F, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2013 Dec 31; 70():623-30. PubMed ID: 24211638
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine-1,4-dione derivatives as anti-Alzheimer's agents.
    Nuha D, Evren AE, Özkan BNS, Gundogdu-Karaburun N, Karaburun AÇ.
    Arch Pharm (Weinheim); 2024 Oct 31; 357(10):e2400067. PubMed ID: 38967191
    [Abstract] [Full Text] [Related]

  • 17. Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach.
    Ganeshpurkar A, Singh R, Kumar D, Gore P, Shivhare S, Sardana D, Rayala S, Kumar A, Singh SK.
    Int J Biol Macromol; 2022 Apr 01; 203():195-211. PubMed ID: 35090939
    [Abstract] [Full Text] [Related]

  • 18. Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents.
    Oliveira C, Bagetta D, Cagide F, Teixeira J, Amorim R, Silva T, Garrido J, Remião F, Uriarte E, Oliveira PJ, Alcaro S, Ortuso F, Borges F.
    Eur J Med Chem; 2019 Jul 15; 174():116-129. PubMed ID: 31029943
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
    Sakayanathan P, Loganathan C, Kandasamy S, Ramanna RV, Poomani K, Thayumanavan P.
    Int J Biol Macromol; 2019 Nov 01; 140():1147-1157. PubMed ID: 31442505
    [Abstract] [Full Text] [Related]

  • 20. 2-Arylbenzofurans from Artocarpus lakoocha and methyl ether analogs with potent cholinesterase inhibitory activity.
    Namdaung U, Athipornchai A, Khammee T, Kuno M, Suksamrarn S.
    Eur J Med Chem; 2018 Jan 01; 143():1301-1311. PubMed ID: 29126732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.